Capital Cell

Capital Cell & Bio Angels Club 🏆 2024 was a record-breaking year for Capital Cell, with €25.2 million raised, our best investment year yet - but you probably already knew that. 🗣️ What you might not know is that Bio Angels Club (BAC) has just launched. Orchestrated by Capital Cell and led by Marc Armet, BAC is Spain’s first private investor network exclusively focused on biotech and healthcare. 🤝 With a high-level expert committee, BAC is set to lead investment rounds in these sectors and make a lasting impact on the entire ecosystem. 🔗 Want to learn more or join? Check the links in the comments!

Last chance to invest in Digital Anatomics! 🚨 With just 2 days to go, Digital Anatomics has reached 101.9% of its funding target, with over €600,000 invested by a community of forward-thinking investors. You can still join the 70+ investors who have already backed this groundbreaking startup that's transforming spinal surgery with AI-powered, personalized 3D-printed surgical guides. This technology has already proved its worth in over 200 surgeries, achieving a 99% success rate in screw placement. ✅ Innovative MedTech solution ✅ Proven clinical success ✅ Poised for significant market growth With just 2 days remaining, don't miss your opportunity to invest in the future of #spinal #surgery. 🔗 https://lnkd.in/dQFpw-tB #investment #biotech #medtech #equitycrowdfunding #DigitalAnatomics #CapitalCell

📢 Calling all #FemTech innovators If you're working on innovative solutions for Female health, we want to hear from you! We're looking for the next game-changing FemTech project for our portfolio. 🏆 What’s in it for you if selected? ✅ Pitch to top investors at our FemTech Demo Day on February 26th. ✅ Potential access to funding from Capital Cell ✅ Join a network shaping innovation in the ecosystem. 👉 Key Criteria: Based in Europe Stage: Pre-seed to Series A Focus: Biotech & Healthcare Preference for women-led companies 🌟 Ready to bring your innovation to the spotlight? Submit your startup by February 9th using this form: https://lnkd.in/dVZt6WqF #FemTech #Biotech #Healthcare #Innovation #WomenInHealth

🧬 "Meet the Founder" with Nacho Esteban, CEO of 24Genetics 🧬 In this interview, Daniel Oliver sits down with Nacho Esteban, who shares his vision for 24genetics, future plans, and details about their ongoing campaign. 🌟 What makes 24genetics stand out? - They’ve tripled their turnover since 2021, now serving customers in over 100 countries worldwide. - Established a global presence with distributors across five continents. - Partnered with leading hospital groups and analytical labs, including Eurofins, one of Europe’s largest. - Achieved significant growth in their B2B segment, which now accounts for 33% of their revenue. 🎥 Watch the full interview here: https://lnkd.in/dtf7NrQa Still have questions for Nacho? Reach out to us—or ask him directly in their next webinar tomorrow at 5 PM. Subscribe here: https://lu.ma/pd4y7cds #Biotech #Genetics #Innovation #HealthTech #CapitalCell

🌟 Just a few days after launching our crowdfunding campaign with Capital Cell, we are thrilled to share that we have already reached an incredible 95.8% of our fundraising goal! We are truly impressed by the amazing #community that is forming to support Aspivix in our mission to revolutionize #womenshealthcare with gentler solutions. It’s inspiring to see so many individuals stepping up, showing their belief in modern gynecology, and committing to making a real difference. 💙 Let’s keep this momentum going—together, we can achieve 100% and even more! If you haven't yet joined, now is the perfect time to be part of this movement. 👉 Join us: https://lnkd.in/dbC5zCJ3 #Aspivix #Crowdfunding #InvestInWomen #WomensHealth #ImpactInvesting

The OxyPrem AG campaign is only €11,000 away from its €2.3 million objective, and we're certain it will reach 100% this week. We won't congratulate CEO Alexander Nitsch and their team ahead of time, but it's great to see that we're nearly there! Also, congratulations to the investor who takes the campaign over the finish line - we will celebrate by sending her/him a nice little present as a special "thank you" 🙂 Check out the campaign & invest here -> https://lnkd.in/d5573y5j

We’re Nearing the Finish Line – Invest today!🌟 Our crowdinvesting campaign is close to the finish line, but there's still an opportunity to go beyond!💡 With oversubscriptions, we can achieve even more for the future of neonatal care. This illustration by Pix Videos shows the new NOAH System, our next-generation technology designed to measure with precision and accuracy.🧠 By investing, you’re not just supporting an innovation that could save countless lives – you’re becoming part of a mission to improve outcomes for the tiniest and most vulnerable patients.🤱 👉 Visit our Capital Cell campaign page at https://lnkd.in/d5573y5j to learn more! Let’s make history together. 💙 #BrainOxygenMonitoring #NeonatalCare #OxyPrem #InnovativeHealthcare #crowdinvesting #neonatology #prematurebirth #brainhealth #investorswanted #nirs #nicu #preemies #newborncare #pretermbirth #preterms

👨🦽➡️🚶♂️ New investment opportunity: Robopedics is revolutionizing mobility solutions for stroke survivors. Their flagship product, AWAKE, is the world's first advanced bionic walking system designed for personal use, enabling individuals with severe disabilities due to stroke to rise from their wheelchairs and walk independently in their daily environments. This groundbreaking technology is 80% more affordable and 60% lighter than existing robotic solutions, making it accessible to a broader population. Robopedics has already secured €423,750 towards their €1,000,000 target, with capital from Clave Capital VC, EconomistesBAN, and Angels like Patricia Ripoll Ros, president of Fundación VISIBLE. Don't miss the chance to invest in a company that's set to transform lives and redefine rehabilitation. Robopedics is led by founder Ivan Martinez (CEO) Marc Serra Bartra ((Business Development Advisor), and Dionís Guzmán, Manager at ISDI Barcelona, as Strategy Advisor. They are also collaborating with Xavier Fernandez as Managing Technology & Design Advisor, contributing to the development of their innovative solutions. More info -> https://lnkd.in/dKxZmktx #InvestmentOpportunity #HealthcareInnovation #StrokeRehabilitation #BionicTechnology #Robopedics

🚀 €1.95 Million Raised by Aspivix🇨🇭to Transform Women’s Health 🚀 The Swiss start-up has reached a significant milestone in its crowdfunding campaign, raising €1.95M from 85 investors to support Carevix™, its innovative device revolutionizing gynecological care. With FDA clearance, CE-Marking, and authorizations in the UK and Brazil, Carevix™ is already changing lives by offering a modern, gentle alternative to the traditional cervical tenaculum—a sharp, clamp-like tool traditionally used to stabilise the cervix during gynaecological procedures. 🌍 The campaign, hosted on Capital Cell, is open until 15 March 2025, aiming to further industrialize and expand Carevix™ into new markets. https://lnkd.in/ezuBKmxS #HealthcareInnovation #FemTech #WomenHealth #Aspivix #Carevix #Crowdfunding

🧑🏻💻 𝗚𝗲𝘁 𝘁𝗼 𝗞𝗻𝗼𝘄: 24Genetics The global genetics market is experiencing rapid growth and is projected to triple in size within the next five years, driven by an annual growth rate of 25%. In such a growing market, marked by some notable failures, 24Genetics has managed to consolidate itself with impressive results: it has tripled its turnover since 2021, has customers in more than 100 countries, distributors on five continents and B2B agreements with large hospital groups and analytical laboratories. 🧬 The company is advancing DNA analysis by integrating AI in personalized health. They provide tailored insights into nutrition, sports, skincare, and preventive health. Capital Cell invites you to a new Get to Know webinar on Tuesday, January 28th, at 17:00 (CET), where you can learn more about 24Genetics' mission, the relevance of this project, and its active investment opportunity. The webinar will feature Nacho Esteban, Founding Partner and CEO of 24Genetics, alongside Francisco Rey, a leader in global finance and investment specialist in exiting startups. 🙌 📲 Webinar will be in English. Registration link here: https://lu.ma/pd4y7cds --- 𝘍𝘰𝘭𝘭𝘰𝘸 Capital Cell 𝘢𝘯𝘥 𝘥𝘪𝘴𝘤𝘰𝘷𝘦𝘳 𝘴𝘰𝘮𝘦 𝘰𝘧 𝘵𝘩𝘦 𝘣𝘦𝘴𝘵 𝘪𝘯𝘷𝘦𝘴𝘵𝘮𝘦𝘯𝘵 𝘰𝘱𝘱𝘰𝘳𝘵𝘶𝘯𝘪𝘵𝘪𝘦𝘴 𝘪𝘯 𝘣𝘪𝘰𝘵𝘦𝘤𝘩, 𝘩𝘦𝘢𝘭𝘵𝘩𝘵𝘦𝘤𝘩, 𝘢𝘯𝘥 𝘭𝘪𝘧𝘦 𝘴𝘤𝘪𝘦𝘯𝘤𝘦 𝘢𝘤𝘳𝘰𝘴𝘴 𝘌𝘶𝘳𝘰𝘱𝘦. 🧪🇪🇺